NFP Sampoorna
NFP Sampoorna Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
FY26 revenue grew 43% to INR 51 crore from INR 35 crore in FY25, driven by better capacity utilization and portfolio diversification. FY26 was the strongest year so far with 43% revenue growth and nearly doubled EBITDA, indicating strong growth momentum.
From NFP Sampoorna's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- FY26 revenue grew 43% to INR 51 crore from INR 35 crore in FY25, driven by better capacity utilization and portfolio diversification.
- Manufacturing of cashews increased from INR 22 crore in FY25 to INR 35 crore in FY26; targeted INR 60-65 crore in FY27.
- Processing volume grew from approx. 1,800-1,900 MT in FY25 to 3,000-3,200 MT in FY26; aiming for 4,000-4,200 MT in FY27 out of 6,000 MT capacity.
- Targeting 85%-90% capacity utilization in next two years with increased working capital and institutional supply penetration.
- Expanding product portfolio beyond cashews to almonds, walnuts, pistachios, and others aiming for 70% revenue from cashew and 30% from other products.
2 more points from NFP Sampoorna's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what NFP Sampoorna said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- NFP Sampoorna Foods is setting up a cashew nut shell liquid (CNSL) processing unit to extract CNSL, which is in demand for industrial uses like paints and coatings.
- The remaining biomass after CNSL extraction will be used as fuel in high-speed boilers.
- Required machinery for CNSL extraction has already been ordered, with commercial production expected by August to September 2026.
2 more points from NFP Sampoorna's call on capex
Pro opens every point from 15K+ earnings calls
Fundraising & Capital Structure
See what NFP Sampoorna said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from NFP Sampoorna's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
Others in Agricultural Food & other Products this season
- Sanstar Ltd (Q1 FY27)
2,062 million, up 21.5% YoY from Rs. Key investor presentation takeaways from Sanstar Ltd's Q1 FY27 investor presentation — and how it ranks against sector peer
- GRM Overseas Ltd (Q1 FY27)
426.5 Crores, up 30.5% YoY from Rs. Key concall takeaways from GRM Overseas Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Amir Chand Jagdish Kumar (Exports) Ltd (Q1 FY27)
663.7 Cr, up 55.1% YoY from Rs. Key concall takeaways from Amir Chand Jagdish Kumar (Exports) Ltd's Q1 FY27 earnings call — and how it ranks against sector…
- Gokul Agro Resources Ltd (Q1 FY27)
EBITDA**: ₹2,330 crore, up 24% year-on-year. Key concall takeaways from Gokul Agro Resources Ltd's Q1 FY27 earnings call — and how it ranks against sector…
Arthneeti Pro · Annual
NFP Sampoorna and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were NFP Sampoorna Q1 FY27 results?
FY26 revenue grew 43% to INR 51 crore from INR 35 crore in FY25, driven by better capacity utilization and portfolio diversification. FY26 was the strongest year so far with 43% revenue growth and nearly doubled EBITDA, indicating strong growth momentum.
What is NFP Sampoorna share price analysis?
NFP Sampoorna currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 5.4 with a market cap of ₹24 Cr. Investors should review the full earnings analysis for detailed insights.
Is NFP Sampoorna planning capital expenditure?
NFP Sampoorna Foods is setting up a cashew nut shell liquid (CNSL) processing unit to extract CNSL, which is in demand for industrial uses like paints and coatings.
Keep NFP Sampoorna on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
